PolyPid Ltd.
Pharmaceutical ManufacturingCentral District, Israel51-200 Employees
PolyPid Ltd. is a pharmaceutical company based in Petah Tikva, Israel, operating as a clinical-stage biopharmaceutical firm focused on developing, manufacturing and offering locally administered therapies aimed at improving surgical outcomes. Its core objective is to deliver medications directly to the surgical site to enable controlled, sustained release over multiple days to months, addressing localized conditions such as infection, pain, inflammation and cancer. The company targets surgical patients and healthcare providers looking to reduce surgical site infections and related complications, including those caused by antibiotic-resistant bacteria, thereby reducing healthcare system burdens. Positioned in the pharmaceutical manufacturing and bio-pharma space, PolyPid emphasizes a platform that anchors treatment at the surgical site to support improved outcomes, with a track record of presenting data from Phase 3 studies and engaging with medical and investor audiences. The company operates at a global level and maintains its headquarters in central Israel, with a focus on advancing its late-stage clinical program and pursuing partnerships and communications within the scientific and regulatory communities.
1-888-653-2347 
support@leadiq.com 
